Cargando…

Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy

Detalles Bibliográficos
Autor principal:	Sadda, Srinivas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608100/ https://www.ncbi.nlm.nih.gov/pubmed/32042181 http://dx.doi.org/10.1038/s41433-020-0802-7

Ejemplares similares

Eplerenone Treatment in Chronic Central Serous Chorioretinopathy
por: Iqbal, Faisal, et al.
Publicado: (2021)

Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature
por: Chatziralli, Irini, et al.
Publicado: (2018)

Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone
por: Anderson, William J., et al.
Publicado: (2022)

A new treatment approach – Eplerenone - in central serous chorioretinopathy - Case report
por: Cioboata, M, et al.
Publicado: (2016)

Real-world practice patterns of eplerenone use for central serous chorioretinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023)

Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study
por: Moein, Hamid-Reza, et al.
Publicado: (2019)

Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy
por: Borrelli, Enrico, et al.
Publicado: (2019)

Routine Clinical Practice Treatment Outcomes of Eplerenone in Acute and Chronic Central Serous Chorioretinopathy
por: Fasler, Katrin, et al.
Publicado: (2021)

Eplerenone Versus Observation in the Treatment of Acute Central Serous Chorioretinopathy: A Retrospective Controlled Study
por: Zucchiatti, Ilaria, et al.
Publicado: (2018)

Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone – a case report
por: Venkatesh, Ramesh, et al.
Publicado: (2020)

Effect of oral eplerenone in anatomical and functional improvement in patients with chronic central serous chorioretinopathy
por: Farooq, Omer, et al.
Publicado: (2019)

An unusual case of multifocal central serous chorioretinopathy with low serum cortisol managed using eplerenone
por: Aggarwal, Kanika, et al.
Publicado: (2019)

Continuous Eplerenone Treatment in Chronic Central Serous Chorioretinopathy: Long-Term Results from a Pilot Study
por: Boscia, Giacomo, et al.
Publicado: (2023)

Update on the pathophysiology and treatment of central serous chorioretinopathy
por: Yu, Seung-Young
Publicado: (2022)

Oral Eplerenone Versus Observation in the Management of Acute Central Serous Chorioretinopathy: A Prospective, Randomized Comparative Study
por: Venkatesh, Ramesh, et al.
Publicado: (2020)

Choriocapillaris Reperfusion in Resolved Chronic Central Serous Chorioretinopathy Treated with Eplerenone: Long-Term Effects on the Fellow Eye
por: Viggiano, Pasquale, et al.
Publicado: (2023)

Short-term comparison between navigated subthreshold microsecond pulse laser and oral eplerenone for chronic central serous chorioretinopathy
por: Toto, Lisa, et al.
Publicado: (2022)

Central serous chorioretinopathy: Treatment
por: Park, Jong Beom, et al.
Publicado: (2022)

Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022)

Central Serous Chorioretinopathy: Treatment with Laser
por: Battaglia Parodi, Maurizio, et al.
Publicado: (2020)

Advances in the treatment of central serous chorioretinopathy
por: Abouammoh, Marwan A.
Publicado: (2015)

Anxiolytics in the treatment of central serous chorioretinopathy
por: Dudani, Ajay I, et al.
Publicado: (2021)

Anxiolytics in the treatment of central serous chorioretinopathy
por: Dudani, Ajay I, et al.
Publicado: (2022)

The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021)

Biomarkers for central serous chorioretinopathy
por: Nkrumah, Gideon, et al.
Publicado: (2020)

Central Serous Chorioretinopathy Classification
por: Vilela, Manuel, et al.
Publicado: (2020)

Traumatic central serous chorioretinopathy
por: Ramchandani, Suresh, et al.
Publicado: (2015)

Traumatic central serous chorioretinopathy
por: Steeples, Laura, et al.
Publicado: (2015)

Atypical Central Serous Chorioretinopathy
por: Cebeci, Zafer, et al.
Publicado: (2017)

Brachytherapy for Central Serous Chorioretinopathy
por: Arora, Supriya, et al.
Publicado: (2022)

Central serous chorioretinopathy in pregnancy
por: Ochinciuc, Radu, et al.
Publicado: (2022)

Efficacy of oral rifampicin in chronic central serous chorioretinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2018)

The Efficacy of Intravitreal Conbercept for Chronic Central Serous Chorioretinopathy
por: Mao, Jianbo, et al.
Publicado: (2019)

Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy: in-vitro optimization and ex-vivo assessment
por: Abdelhakeem, Eman, et al.
Publicado: (2021)

Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016)

Treatment of central serous chorioretinopathy with topical NSAIDs
por: Bahadorani, Sepehr, et al.
Publicado: (2019)

Systemic complement activation in central serous chorioretinopathy
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Central serous chorioretinopathy secondary to trauma
por: Jackson, Thomas E., et al.
Publicado: (2012)

Central Serous Chorioretinopathy after Rhinoplasty
por: Moschos, Marilita M., et al.
Publicado: (2010)

Photodynamic Therapy and Central Serous Chorioretinopathy
por: Siaudvytyte, Lina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4sds223qg0io5jj8ue0q5m2ub4